Pulmonx Corporation Gross Profit 2019-2024 | LUNG
Pulmonx Corporation gross profit from 2019 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| Pulmonx Corporation Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $51 |
| 2022 | $40 |
| 2021 | $36 |
| 2020 | $21 |
| 2019 | $22 |
| 2018 | $12 |
| Pulmonx Corporation Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-09-30 | $15 |
| 2024-06-30 | $15 |
| 2024-03-31 | $14 |
| 2023-12-31 | $14 |
| 2023-09-30 | $13 |
| 2023-06-30 | $13 |
| 2023-03-31 | $11 |
| 2022-12-31 | $11 |
| 2022-09-30 | $10 |
| 2022-06-30 | $10 |
| 2022-03-31 | $8 |
| 2021-12-31 | $10 |
| 2021-09-30 | $10 |
| 2021-06-30 | $9 |
| 2021-03-31 | $7 |
| 2020-12-31 | $7 |
| 2020-09-30 | $7 |
| 2020-06-30 | $1 |
| 2020-03-31 | $6 |
| 2019-12-31 | |
| 2019-09-30 | $6 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.354B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||